Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules
Fig 4
Signature exposure plots showing the activities of the extracted mutation signatures over the duration of the COVID-19 pandemic.
A. Shows the percentage activity of the signatures during a given week of the pandemic, with each colour representing a different signature. B. Shows the signature activities as their absolute values at each epidemic week.